See more : Aurisco Pharmaceutical Co.,Ltd. (605116.SS) Income Statement Analysis – Financial Results
Complete financial analysis of CannAmerica Brands Corp. (CNNXF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CannAmerica Brands Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Public Storage (PSA-PJ) Income Statement Analysis – Financial Results
- Barton Gold Holdings Limited (BGD.AX) Income Statement Analysis – Financial Results
- Aadi Industries Limited (AADIIND.BO) Income Statement Analysis – Financial Results
- Global Communication Planning Co.,Ltd. (4073.T) Income Statement Analysis – Financial Results
- Shenzhen Breo Technology Co., Ltd. (688793.SS) Income Statement Analysis – Financial Results
CannAmerica Brands Corp. (CNNXF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannamericabrands.com
About CannAmerica Brands Corp.
CannAmerica Brands Corp. owns a portfolio of brands of medical cannabis and recreational cannabis products. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors in the states of Colorado, Nevada, Oklahoma, and Massachusetts. It offers cannabis infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products under the CannAmerica brand. The company is headquartered in Vancouver, Canada.
| Metric | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 386.49K | 642.92K | 732.67K | 0.00 |
| Cost of Revenue | 58.08K | 1.32M | 2.10M | 0.00 |
| Gross Profit | 328.42K | -672.97K | -1.37M | 0.00 |
| Gross Profit Ratio | 84.97% | -104.67% | -187.13% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 990.25K | 2.47M | 3.57M | 0.00 |
| Selling & Marketing | 303.56K | 747.77K | 1.73M | 0.00 |
| SG&A | 1.29M | 1.03M | 2.62M | 0.00 |
| Other Expenses | -965.39K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 328.42K | 1.03M | 2.62M | 0.00 |
| Cost & Expenses | 386.49K | 2.34M | 4.72M | 0.00 |
| Interest Income | -2.49K | -3.06K | -14.47K | 0.00 |
| Interest Expense | 511.55K | 241.35K | 107.06K | 0.00 |
| Depreciation & Amortization | 19.44K | 12.03K | 3.74K | 0.00 |
| EBITDA | -3.02M | -3.00M | -6.62M | 0.00 |
| EBITDA Ratio | -781.38% | -262.61% | -543.84% | 0.00% |
| Operating Income | -984.83K | -1.70M | -3.99M | 0.00 |
| Operating Income Ratio | -254.81% | -264.48% | -544.35% | 0.00% |
| Total Other Income/Expenses | -1.84M | -1.55M | -2.75M | 0.00 |
| Income Before Tax | -2.83M | -3.25M | -6.73M | 0.00 |
| Income Before Tax Ratio | -731.00% | -506.03% | -919.11% | 0.00% |
| Income Tax Expense | 2.00 | 7.03 | -59.88K | 0.00 |
| Net Income | -3.55M | -3.25M | -6.67M | 0.00 |
| Net Income Ratio | -918.76% | -506.03% | -910.94% | 0.00% |
| EPS | -0.06 | -0.06 | -0.17 | 0.00 |
| EPS Diluted | -0.06 | -0.06 | -0.17 | 0.00 |
| Weighted Avg Shares Out | 56.04M | 53.24M | 38.65M | 49.68M |
| Weighted Avg Shares Out (Dil) | 56.04M | 53.24M | 38.65M | 49.68M |
Source: https://incomestatements.info
Category: Stock Reports